National Comprehensive Cancer Network



About NCCN

Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel - Disclosures as of 10/8/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

Wallace Akerley, MD

None

Genentech, Inc.

None

None

None

Hossein Borghaei, DO, MS

None

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.

None

None

None

Andrew C. Chang, MD

None

None

None

None

None

Richard T. Cheney, MD

None

None

None

None

None

Lucian R. Chirieac, MD

None

None

None

None

None

Thomas A. D'Amico, MD

None

Covidien AG;
Scanlan

None

None

None

Todd L. Demmy, MD

None

None

None

None

None

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Biodesix, Inc.;
Poniard Pharmaceuticals, Inc.;
Prometheus;
Shin Nippon Biomedical Labs;
Telik, Inc.

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Ramaswamy Govindan, MD

None

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Genentech, Inc.;
sanofi-aventis U.S.

None

None

None

Frederic W. Grannis, MD

None

Steven Phillips (sphillips@lpklaw.com)

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Leora Horn, MD, MSc, FRCPC

None

None

None

None

None

Miranda Hughes, PhD

None

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

Thierry M. Jahan, MD

None

Poniard Pharmaceuticals

None

None

None

Anne Kessinger, MD

Pharmacyclics;
sanofi-aventis U.S.

None

None

None

None

Ritsuko Komaki, MD

None

None

None

None

None

Feng-Ming (Spring) Kong, MD, PhD

None

None

None

None

None

Mark G. Kris, MD

None

Boehringer Ingelheim GmbH;
Celgene Corporation;
Daiichi- Sankyo Co.;
GlaxoSmithKline;
Merck & Co., Inc.;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Chugai Pharmaceutical;
EMD Serono;
Syndax Pharmaceuticals, Inc

None

None

None

Lee M. Krug, MD

None

Baxter International Inc.;
GlaxoSmithKline;
Johnson & Johnson;
Morphotek Inc.;
Poniard

None

None

None

Inga T. Lennes, MD, MPH, MBA

None

None

None

None

None

Billy W. Loo, MD, PhD

None

Accuray Incorporated;
SuperDimension

None

None

None

Renato Martins, MD, MPH

None

Eli Lilly and Company;
Genentech, Inc.

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Janis O'Malley, MD

None

None

None

None

None

Raymond U. Osarogiagbon, MD, FACP

None

Genentech, Inc.;
Genentech, Inc.;
OSI Pharmaceuticals, Inc.

None

None

None

Gregory A. Otterson, MD

None

Eli Lilly and Company;
Genentech, Inc.

None

None

None

Jyoti D. Patel, MD

None

Eli Lilly and Company;
Genentech, Inc.

None

None

None

Mary C. Pinder-Schenck, MD

None

None

None

None

None

Katherine M. Pisters, MD

None

None

None

None

None

Karen Reckamp, MD, MS

None

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Response Genetics;
Tragara Pharmaceuticals

None

None

None

Gregory J. Riely, MD, PhD

None

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company

None

None

None

Eric Rohren, MD, PhD

None

None

None

None

None

Scott Swanson, MD

None

Covidien AG;
Ethicon, Inc.

None

None

None

Douglas E. Wood, MD

None

None

None

None

None

Stephen C. Yang, MD

None

None

None

None

None